Enzyme-linked immunosorbent assay (ELISA) has been used to study the levels of antibody binding to the soluble antigens of Mycobacterium tuberculosis (BCG) in the IgG, IgM and IgA classes in sera from patients with tuberculosis, sarcoidosis and Crohn's disease. Of the patients with tuberculosis, 75% had significantly elevated levels of anti-M. tuberculosis antibodies in the IgG class. The levels of antibodies in the IgM and IgA classes were much less discriminative. Many of the patients with sarcoidosis and Crohn's disease had significantly elevated levels of antimycobacterial antibodies, principally in the IgM and IgA classes. These elevated levels of antibody were not related to the total levels of the immunoglobulin classes. For the purpose of serodiagnosis, an estimation of the antimycobacterial antibodies in the IgG class gives the most discriminative results.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0041-3879(80)90003-3DOI Listing

Publication Analysis

Top Keywords

sarcoidosis crohn's
12
crohn's disease
12
igm iga
12
iga classes
12
elevated levels
12
enzyme-linked immunosorbent
8
immunosorbent assay
8
assay elisa
8
elisa study
8
mycobacterium tuberculosis
8

Similar Publications

Refining the clinical and therapeutic spectrum of granulomatous myositis from a large cohort of patients.

J Neurol

January 2025

Sorbonne Université, Assistance Publique, Hôpitaux de Paris, Inserm U974, Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Paris, France.

Objectives: Granulomatous myositis (GM) is a rare entity whose precise clinical features and therapeutic outcomes have not yet been well defined. Given the limited evidence, data from a large cohort of patients is needed to aid in the recognition and management of this condition.

Methods: We retrospectively analyzed our institutional databases to identify patients who had myositis and non-caseating granuloma on muscle biopsy (GM).

View Article and Find Full Text PDF

Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases.

Diabetes Metab Syndr

January 2025

Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. Electronic address:

Objective: To investigate the causal association of using glucagon-like peptide-1 receptor (GLP1R) agonists with autoimmune diseases.

Methods: The available cis-eQTLs for drugs target genes (GLP1R) were used as genetic variants for exposure to GLP1R agonists. Type 2 diabetes was used as positive control.

View Article and Find Full Text PDF

BACKGROUND Necrobiotic pulmonary nodules represent an exceptionally rare extraintestinal manifestation of inflammatory bowel disease (IBD), comprising conditions such as Crohn's disease and ulcerative colitis. These nodules pose significant diagnostic challenges, often mimicking autoimmune pathologies like sarcoidosis, rheumatoid arthritis, and other granulomatous diseases, thereby complicating the clinical management of affected patients. The rarity and nonspecific clinical presentation of necrobiotic pulmonary nodules necessitate a reliance on a combination of radiological and histological findings for accurate diagnosis.

View Article and Find Full Text PDF
Article Synopsis
  • - Crohn's disease (CD) is a rising chronic inflammatory bowel condition that's tough to diagnose due to unclear criteria, often needing teamwork between doctors and pathologists.
  • - The disease typically shows transmural inflammation and can include rare features like Schaumann bodies (SB), which are seldom found in CD cases (around 10%).
  • - A case of a 4-year-old girl with severe symptoms led to the discovery of SB in her gastric mucosa, helping to confirm her diagnosis of early-onset CD and demonstrating the need to differentiate it from similar diseases.
View Article and Find Full Text PDF
Article Synopsis
  • Crohn's disease (CD) is a chronic inflammatory condition of the intestines with symptoms like abdominal pain and diarrhea, and granulomas are the most recognized indicator for diagnosing it, though their detection can vary significantly.
  • A case study of a 28-year-old woman with CD revealed both caseating and non-caseating granulomas, which improved with treatment.
  • The findings suggest that caseous granulomas shouldn't rule out CD as a diagnosis, even in the absence of other conditions like tuberculosis, highlighting the complexity of diagnosing this disease.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!